Oncologic Disorders Clinical Trial
— MGPEC_OncoOfficial title:
Place of General Medical During Oncology Care Management
NCT number | NCT03416465 |
Other study ID # | 2017-A03429-44 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | May 16, 2018 |
Est. completion date | May 16, 2019 |
Verified date | August 2020 |
Source | Institut de Cancérologie de Lorraine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The Purpose of MGPEC_ONCO is to see if patient consult their general practitioner during the
management of their cancer, especially before hospitalization. The study concerns not planned
hospitalizations in medicine service.
Before leaving hospital, the patient completes the survey, other data are taken in patient
record
Status | Completed |
Enrollment | 197 |
Est. completion date | May 16, 2019 |
Est. primary completion date | May 16, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patient undergoing oncology treatment or = 1 year of the latest oncology treatments - Patient hospitalized in a medical service in an unscheduled way - Age > or = 18 years old - Patient informed and not opposed to the study - Patient able and agreeing to follow all study procédures - Patient must be affiliated to a social security system Exclusion Criteria: - Patient hospitalized in surgery and continuing care services - Patient deprived of liberty or under supervision |
Country | Name | City | State |
---|---|---|---|
France | Institut de Cancérologie de Lorraine | Vandœuvre-lès-Nancy |
Lead Sponsor | Collaborator |
---|---|
Institut de Cancérologie de Lorraine |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Patients in unscheduled hospitalization | Percentage of patients in unscheduled hospitalization who have seen their general practitioner | 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT01210716 -
Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device
|
Phase 3 | |
Completed |
NCT05478733 -
Study of Factors Associated With Significant MYoCArdian Uptake on 68Ga-DOTATOC PET Scans for Oncology
|
||
Terminated |
NCT03978312 -
Nutrition Health Literacy of Cancer Patients and Their Support Networks.
|
||
Not yet recruiting |
NCT04142463 -
Collaborative Network to Take Responsibility for Oral Anticancer Therapy 2
|
N/A | |
Recruiting |
NCT06229535 -
The Right to be Forgotten in the AYA Population: Patients' Experience and Perspectives (Diritto All'Oblio)
|
||
Completed |
NCT04420039 -
Plastic Stent Within a Lumen-Apposing Stent for Malignant Biliary Obstruction
|
||
Withdrawn |
NCT03041571 -
Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students
|
||
Completed |
NCT02484053 -
Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders
|
Early Phase 1 | |
Completed |
NCT03030248 -
Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients
|
Phase 2 | |
Not yet recruiting |
NCT03168048 -
Oncologic Therapy Support Via Means of a Dedicated Mobile App
|
N/A | |
Completed |
NCT03426553 -
Clinical Use of Pathogen Reduced Red Blood Cell Suspension
|
Phase 3 | |
Completed |
NCT04271670 -
Effect of Warm Water Footbaths With Added Ginger or Mustard Powder on Psychosocial Parameters in Patients With an Oncological Disease
|
N/A | |
Active, not recruiting |
NCT04842214 -
Disease Course in Oncological Patients During Inpatient Rehabilitation and After Three Months Follow-up
|
||
Completed |
NCT03272646 -
Prognostic Performance of the Naples Prognostic Score
|
N/A | |
Terminated |
NCT02285296 -
The Needs and Burden of Family Caregivers of Older Adults With Cancer
|
N/A | |
Completed |
NCT04918888 -
COVID-19 Vaccination in Oncologic Patients
|
||
Recruiting |
NCT05769868 -
Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments
|
Phase 3 |